ArticleScientific reports2026
LncRNA TUG1 mitigates sepsis-induced acute lung injury via a ceRNA network regulating the CALM1/PRKG1/RYR3/AQP5 axis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sepsis-induced acute lung injury (ALI) is a life-threatening condition associated with high mortality, yet the molecular mechanisms driving alveolar damage remain incompletely understood. Long non-coding RNA (lncRNA) TUG1 has been implicated in organ injury, but its specific role and regulatory network in septic ALI have not been fully elucidated.Using lipopolysaccharide (LPS)-treated mouse lung epithelial (MLE-12) cells and a murine model of ALI, we investigated the functional role of TUG1 through overexpression strategies. Gene expression, protein levels, inflammatory cytokines, and miRNA interactions were assessed via qPCR, Western blotting, ELISA, and dual-luciferase reporter assays. Bioinformatic analysis of public datasets (GSE241238, GSE48080) was performed to validate clinical relevance.TUG1 expression was significantly downregulated in LPS-induced ALI models. TUG1 overexpression mitigated inflammation and oxidative stress by acting as a competing endogenous RNA (ceRNA) for miR-222-3p, thereby derepressing CALM1. Activation of CALM1 subsequently engaged the PRKG1/RYR3 signaling cascade, leading to restoration of AQP5-mediated alveolar fluid clearance. Analysis of public datasets confirmed suppression of the TUG1/CALM1 axis in septic patients and revealed its association with adverse survival outcomes. While the preliminary sample sizes (n = 3 in vitro, n = 5 in vivo) limit the statistical power (post-hoc 0.65), the robust trends support the TUG1 axis as a potential target, though larger cohort validation is needed.This study identifies TUG1 as a potential modulator of sepsis-induced ALI through the miR-222-3p/CALM1/PRKG1/RYR3/AQP5 axis. These findings underscore the therapeutic potential of targeting TUG1 to alleviate septic lung injury. These findings identify TUG1 as a protective lncRNA that acts via the miR-222-3p/CALM1 axis to regulate calcium signaling and alveolar fluid clearance. Targeting this pathway may offer a novel therapeutic strategy for sepsis-induced ALI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.